Delcath Systems (DCTH) Capital Expenditures Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 10.17% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.81% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.35% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.08% |
| 10 | Delcath Systems | 383.27 Mn | 293.95 Mn | 21.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 88.99% |
| Jun 30, 2025 | 97.07% |
| Mar 31, 2025 | 16.30% |
| Dec 31, 2024 | 513.58% |
| Sep 30, 2024 | 56.83% |
| Jun 30, 2024 | 8.53% |
| Mar 31, 2024 | 13.04% |
| Dec 31, 2023 | -36.44% |
| Sep 30, 2023 | -26.04% |
| Jun 30, 2023 | -0.82% |
| Mar 31, 2022 | 254.37% |
| Dec 31, 2021 | -27.22% |
| Sep 30, 2021 | 40.95% |
| Jun 30, 2021 | 33.77% |
| Mar 31, 2021 | 14.47% |
| Dec 31, 2020 | -21.33% |
| Sep 30, 2020 | 71.82% |
| Jun 30, 2020 | -42.71% |
| Mar 31, 2020 | 45.86% |
| Dec 31, 2019 | 19.17% |
| Mar 31, 2019 | -48.91% |
| Dec 31, 2018 | -25.43% |
| Sep 30, 2018 | -21.91% |
| Jun 30, 2018 | -7.72% |
| Mar 31, 2018 | -48.91% |
| Dec 31, 2017 | 51.17% |
| Dec 31, 2016 | -23.47% |
| Sep 30, 2016 | 64.01% |
| Jun 30, 2016 | 21.14% |
| Mar 31, 2016 | -23.87% |
| Dec 31, 2015 | -2.33% |
| Sep 30, 2015 | -62.92% |
| Jun 30, 2015 | -60.47% |
| Mar 31, 2015 | -57.15% |
| Dec 31, 2014 | -49.02% |
| Dec 31, 2013 | -53.90% |
| Sep 30, 2013 | -55.18% |